Lee Chang-sun’s Aprogen Biologics Stake Falls to Zero From 16.95% After Convertible Bond Deal Cancellation

Bitget2026/10/26 06:43

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Leechangsun's reported holding in Aprogen Biologics fell to zero from 16.95%, a reduction of 3,262,642 share equivalents.
The change on Oct. 6, 2026, resulted from termination of a convertible bond purchase agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprogen Biologics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026000181), on October 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Intel disclosed that CEO Pat Gelsinger purchased 150,000 shares of Intel common stock on the open market on November 2nd, at a weighted average price of $64.7312 per share, with a transaction amount of approximately $9.71 million. The purchase was made through a family trust, and after the transaction, the trust's Intel holdings increased to 1.4647 million shares, up around 11.4% from before the transaction. Following the announcement, Intel’s share price briefly rallied, narrowing its decline to 1.2% before retreating again.

华尔街见闻•2026/11/04 19:17